M. Li et al., TRANSCRIPTIONAL REGULATION OF OCI-5 GLYPICAN-3 - ELONGATION CONTROL OF CONFLUENCE-DEPENDENT INDUCTION/, Oncogene, 15(13), 1997, pp. 1535-1544
OCI-5/Glypican 3, a member of the glypican family of proteoglycans, is
the defective gene in the Simpson-Golabi-Behmel overgrowth syndrome.
OCI-5 expression is developmentally regulated in the intestinal epithe
lium, and the mechanism of its regulation was studied in the rat intes
tinal epithelial cell line IEC-18. A large induction of OCI-5 transcri
pt and protein was observed at high cell density, Among other glypican
family members, kappa-glypican also exhibited a confluence-dependent
induction in select cell types. Nuclear run-on analysis indicated that
cell-density regulation of OCI-5 occurs at the level of transcription
, The rat and mouse OCI-5 promoters were cloned and found to be highly
conserved, located within CpG islands and contain regions of alternat
ing purine and pyrimidine residues, No TATA-box or recognizable INR el
ement was observed, Consensus binding sites for AP-2, SP-1, zeste and
NF-1/CTF are conserved across human, mouse and rat promoters, 5' delet
ion mapping of the rat promoter identified regions which enhance and r
epress promoter activity, with no apparent confluence-dependence or ti
ssue-specificity. Nuclear run-on analysis probing different regions of
the gene suggests that elongation control plays a role in the inducti
on of OCI-5 by confluence.